# Fibromyalgia Health Outcome Study on Cost of Treatments

> **NCT00725101** · — · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 1700 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Treatment for Fibromyalgia

## Key facts

- **NCT ID:** NCT00725101
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 1700 (ACTUAL)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725101, "Fibromyalgia Health Outcome Study on Cost of Treatments". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00725101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*